Liquid Cardiac Control — Class II medical device recall Z-1785-2019
Terminated recall by Randox Laboratories Ltd., reported 2019-06-26, distributed in CA, DE, PR, WV. Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Con
| Recall number | Z-1785-2019 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Randox Laboratories Ltd., Crumlin (North), N/A, Ireland |
| Recall initiated | 2019-03-11 |
| Classified | 2019-06-14 |
| Reported by FDA | 2019-06-26 |
| Terminated | 2020-05-15 |
| Distributed | CA, DE, PR, WV |
| Quantity | 11,420 kits |
| Lot numbers | 4243CK, 4244CK, 4245CK |
| Model numbers | CQ5051, CQ5052, CQ5053 |
Product
Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053
Reason for recall
Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1785-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.